Forest Laboratories, Inc. (NYSE:FRX)
The Company and its subsidiaries develop, manufacture and sell both branded and generic forms of ethical drug products which require a physician's prescription, as well as non-prescription pharmaceutical products sold over-the-counter.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Recs
GettingtobeaGuru
(56.81)
Submitted: 1/12/2012 10:14:36 AM :
Start Price:
$31.32
FRX Score:
-3.59
This is an outperform call banking on a share buyback (or something good like that) with all that cash they are stockpiling.
Recs
shake656
(81.87)
Submitted: 11/7/2011 5:38:11 PM :
Start Price:
$30.66
FRX Score:
-2.99
Under priced.
Recs
damian666
(< 20)
Submitted: 6/20/2011 7:57:33 AM :
Start Price:
$38.67
FRX Score:
-24.55
Strong pipeline, loads of cash and an interest from Mr. Ichan
Recs
Recs
hoboinvest
(< 20)
Submitted: 4/8/2011 11:25:28 PM :
Start Price:
$32.98
FRX Score:
-5.39
One word, MRSA. They have the drug to fight it.
Recs
jemsa
(28.21)
Submitted: 3/28/2011 1:01:09 PM :
Start Price:
$31.01
FRX Score:
-0.40
Value Stocks Screen Multiple Ratios
Recs
sandeeparoras
(31.84)
Submitted: 12/9/2010 5:34:07 AM :
Start Price:
$32.13
FRX Score:
-10.28
Technical Indicator: LCR-20
Recs
H20jo52
(85.23)
Submitted: 10/15/2010 10:03:57 AM :
Start Price:
$33.27
FRX Score:
-19.76
patents that it holds
Recs
bobmacmaster
(< 20)
Submitted: 10/10/2010 11:11:33 AM :
Start Price:
$31.89
FRX Score:
-16.21
This company has carved out a profitable niche
Recs
Recs
citizenryan
(68.68)
Submitted: 8/17/2010 6:34:46 PM :
Start Price:
$27.99
FRX Score:
-9.98
This is the one of the the hardest stock to predict. Lexapro is the 2nd most prescribed drug in America. Government rules regarding patents mean the drug will go generic in 2012. This means FRX's major revenue stream will dry up.
In 2011 people will start selling. Until then it's do well.
With no end in sight for the recession people will continue to be depressed and doctors will prescribe anti-depressant. There is plenty of research on the relationship between recessions (or future outlooks) and depression
Recs
dsp444
(85.22)
Submitted: 7/23/2010 1:15:00 PM :
Start Price:
$28.14
FRX Score:
-10.23
On 30 stocks over $50 million market cap magic formula screen
owned for the past year as part of my Magic Formula portfolio. I should be selling it this month, but it is still showing up on the Magic Formula screen. Lots of cash flow and a big cash hoard with no debt. The question is what are they going to do with all that money. There was a new share repurchase program approved by the board in May 2010 for 50 million shares, but there is not plan on when to carry that out. Earnings have been weakening the past couple of years, but I see no big reason to sell, so I will hold onto this stock for another year with my real money Magic Formula portfolio.
Recs
cibient
(89.47)
Submitted: 6/10/2010 2:49:55 PM :
Start Price:
$25.72
FRX Score:
-0.96
MFI Top 50, amazing balance sheet, $500M stock buyback program.
Recs
DDSDH
(< 20)
Submitted: 6/2/2010 1:19:20 AM :
Start Price:
$25.55
FRX Score:
-0.87
I can't find anything negative about this company. Solid all around.
Recs
CapitalBeliefs
(< 20)
Submitted: 5/2/2010 12:49:32 AM :
Start Price:
$26.98
FRX Score:
+4.75
The company is shareholder focused with a strong pipeline on drugs on the horizon. The company has $2b cash to acquire licensing agreements with foreign drug companies wanting access to a non-competitor US sales team.
Trading at a 45% discount to its intrinsic value, I am looking for 20% compounded growth over the next 3 to 5 years.
Recs
pittajames
(89.86)
Submitted: 4/18/2010 11:06:05 AM :
Start Price:
$27.79
FRX Score:
+0.60
nice entry point for this major pipeline
Recs
syljtffreedom
(94.39)
Submitted: 4/6/2010 3:11:50 AM :
Start Price:
$30.80
FRX Score:
-11.06
depression cases on the rise during crisis
Recs
GrahamJervis
(66.50)
Submitted: 2/17/2010 3:35:01 PM :
Start Price:
$29.66
FRX Score:
-15.56
Free cash flow gusher with great drugs in the pipeline.
Recs
sleepingdragon
(< 20)
Submitted: 2/2/2010 2:23:54 AM :
Start Price:
$29.43
FRX Score:
-17.17
Selling at a very cheap price. Should be able to come with something to overcome pipeline problems.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 68 : 1 2 3 4 Next »